NASDAQ:INSP - Inspire Medical Systems Stock Price, News, & Analysis

$56.55
+1.18 (+2.13 %)
(As of 06/17/2019 10:42 AM ET)
Today's Range
$55.13
Now: $56.55
$56.55
50-Day Range
$49.24
MA: $53.36
$58.13
52-Week Range
$33.06
Now: $56.55
$64.34
Volume2,148 shs
Average Volume331,117 shs
Market Capitalization$1.35 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INSP
CUSIPN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$1.35 billion
Next Earnings Date8/6/2019 (Estimated)
OptionableOptionable

Receive INSP News and Ratings via Email

Sign-up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems (NASDAQ:INSP) released its quarterly earnings results on Tuesday, May, 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.39) by $0.04. The business had revenue of $16.30 million for the quarter, compared to analysts' expectations of $17.79 million. The firm's revenue for the quarter was up 63.0% compared to the same quarter last year. View Inspire Medical Systems' Earnings History.

When is Inspire Medical Systems' next earnings date?

Inspire Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Inspire Medical Systems.

What price target have analysts set for INSP?

3 analysts have issued 12 month price targets for Inspire Medical Systems' shares. Their forecasts range from $31.00 to $64.00. On average, they anticipate Inspire Medical Systems' share price to reach $50.6667 in the next year. This suggests that the stock has a possible downside of 8.5%. View Analyst Price Targets for Inspire Medical Systems.

What is the consensus analysts' recommendation for Inspire Medical Systems?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.

Has Inspire Medical Systems been receiving favorable news coverage?

News coverage about INSP stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Inspire Medical Systems earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Inspire Medical Systems.

Who are some of Inspire Medical Systems' key competitors?

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Intelsat (I), Chaarat Gold (CGH), Alibaba Group (BABA), Bank of America (BAC), Associated British Foods (ABF), Fossil Group (FOSL), AMC Entertainment (AMC), Ciena (CIEN), First Data (FDC) and Thermo Fisher Scientific (TMO).

Who are Inspire Medical Systems' key executives?

Inspire Medical Systems' management team includes the folowing people:
  • Mr. Tim Herbert, Chief Exec. Officer and Pres
  • Mr. Richard Buchholz, Chief Financial Officer
  • Mr. Randy Ban, Sr. VP of Sales and Marketing
  • Mr. Sean Cleary, VP of Global Market Devel.
  • Mr. Gary A. Goetzke, VP of Health Economics

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (4.60%), OppenheimerFunds Inc. (2.22%), KPCB XII Associates LLC (1.69%), TimesSquare Capital Management LLC (1.55%), Federated Investors Inc. PA (1.42%) and Columbus Circle Investors (1.00%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.

Which institutional investors are selling Inspire Medical Systems stock?

INSP stock was sold by a variety of institutional investors in the last quarter, including KPCB XII Associates LLC, TimesSquare Capital Management LLC, Pier Capital LLC, JPMorgan Chase & Co., EAM Global Investors LLC and Cetera Advisors LLC. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

Which institutional investors are buying Inspire Medical Systems stock?

INSP stock was purchased by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, OppenheimerFunds Inc., Columbus Circle Investors, Victory Capital Management Inc., Spark Investment Management LLC, Wasatch Advisors Inc., Kornitzer Capital Management Inc. KS and Timpani Capital Management LLC. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.

How do I buy shares of Inspire Medical Systems?

Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $55.37.

How big of a company is Inspire Medical Systems?

Inspire Medical Systems has a market capitalization of $1.32 billion. View Additional Information About Inspire Medical Systems.

What is Inspire Medical Systems' official website?

The official website for Inspire Medical Systems is http://www.inspiresleep.com/.


MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  138
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel